Metropolis Healthcare Limited has informed the Exchange about change in Management

Management Changes View source PDF Explain this filing

METROPOLIS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-6.0%Reaction day

₹428.10

prior close

₹423.50

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.6%-7.6% vs market

Healthcare Service Provider peers, median of 22sector+0.1%-6.1% vs sector

On the reaction day the stock moved 7.6 pts less than Nifty Microcap 250 and 6.1 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.2

10m

-1.8

15m

-2.2

30m

-1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-6.0+1.6-7.6+0.1-6.1

Next day

-5.2+2.6-7.8+0.2-5.3

-3.6+3.4-7.1+0.0-3.6

-4.2+4.7-8.9-0.9-3.4

-3.1+3.6-6.6-0.4-2.6

-2.5+4.4-6.8+1.4-3.9

-4.6+4.9-9.6+0.9-5.6

15d

-1.1+6.8-7.9+0.0-1.1

-0.1+8.4-8.5+4.6-4.7

+9.6+10.0-0.4+3.6+6.0

+23.8+4.7+19.2+6.3+17.5

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Metropolis Healthcare Limited has informed the stock exchange about a change in its management team. The specific nature of the change, the individual(s) involved, and whether it is a resignation, appointment, or restructuring have not been detailed in the headline. Further clarity is needed from the full filing to understand the role, person, and direction of the change.

Likely market impact

For now, the impact is unclear due to limited information. Once the full details are disclosed (who, what role, and reason), investors should reassess for any governance or strategic implications.